CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 94 enrolled
Drug / intervention
dutasteride + ethanol +3 moredrug
Likely dose
dutasteride + ethanol 4 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00734656
NCT00734656N/ACompleted

Subjective and Physiological Effects of Alcohol: Role of Genetic Variation and Adrenal Hormones

UConn Health·interventional·Posted Aug 14, 2008·Updated Mar 28, 2012

In Brief

A clinical study evaluating dutasteride + ethanol, placebo medication + ethanol, and 2 other interventions for Alcohol Related Disorders and 2 related conditions. Completed, enrolled 94 participants across 1 site.

Detailed Summary

This study will explore the hypothesis that effects of alcohol are in part mediated by increased production of neuroactive steroids, which interact with GABAA-receptors. We propose to study non-dependent drinkers using a 4-session within-subjects design in which alcohol / placebo is paired with dutasteride / placebo pretreatment. Dutasteride is a 5-alpha steroid reductase (5AR) inhibitor that limits the production of dihydrotestosterone and the 5a-reduced neuroactive steroids allopregnanolone, pregnanolone and 3a,5a-androstanediol.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedAug 14, 2008
Enrollment StartMar 1, 2007
Primary CompletionOct 1, 2010
Study CompletionJul 1, 2011
TodayJul 2, 2026
Enrollment to primary: 3.6 yearsPosted 17.9 years ago

Interventions

dutasteride + ethanoldrug

4 mg dutasteride administered 2-4 days prior to ingestion of 0.8 mg/kg ethanol divided between three drinks consumed over 36 minutes

placebo medication + ethanoldrug

placebo medication administered 2-4 days prior to ingestion of 0.8 gr/kg ethanol divided between three drinks consumed over 36 minutes

dutasteride + placebo alcoholdrug

4 mg dutasteride administered 2-4 days prior to ingestion of three drinks each containing 1 cc ethanol consumed over 36 minutes

placebo medication + placebo alcoholdrug

placebo medication administered 2-4 days prior to ingestion of three drinks each containing 1 cc ethanol consumed over 36 minutes